Biotech

All Articles

Novo Nordisk centers once-monthly GLP-1\/ GIP agonist, MASH prospect

.Novo Nordisk has axed its once-monthly dual GLP-1/ GIP receptor agonist, ending (PDF) development o...

Daiichi spends Merck $170M to form lung cancer T-cell engager contract

.Merck &amp Co. has swiftly recouped a number of the prices of its own Javelin Rehabs buyout, drawin...

BioMarin halts preclinical genetics therapy for heart condition

.After BioMarin carried out a springtime clean of its pipe in April, the company has actually made a...

Eisai plants molecular glue SEED along with $1.5 B biobucks handle

.Big Pharmas remain caught to the tip of molecular adhesive degraders. The current firm to observe a...

Life science credit score company introduces with $600M

.A brand new international life science credit rating company, referred to Symbiotic Capital, has ac...

BMS channels TIGIT, bowing out $200M bank on Agenus bispecific

.Bristol Myers Squibb is actually axing one more huge bet coming from the Caforio era, ending a pack...

Nuvation standstills BET inhibitor after thinking about period 1 data

.After checking out at stage 1 information, Nuvation Bio has actually made a decision to halt focus ...

' Clinical intuition' led FDA experts to support Zevra's unusual ailment med

.Zevra Therapeutics' uncommon condition drug seems to be to be on the course to authorization this f...

Pfizer takes $230M hit after axing stopped working DMD gene therapy

.Pfizer's stage 3 Duchenne muscular dystrophy (DMD) genetics treatment failure has actually blown a ...

AC Immune sees 'spots' potential in Alzheimer's medication data

.After more than two decades of focus on neurodegenerative diseases, Swiss biotech AC Immune system ...